{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:20:27Z","timestamp":1787916027338,"version":"build-2784847793"},"reference-count":41,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"unspecified","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Jadran-Galenski Laboratorij d.d.","award":["in-kind support"],"award-info":[{"award-number":["in-kind support"]}]},{"name":"Clinical Hospital Center Rijeka","award":["in-kind support"],"award-info":[{"award-number":["in-kind support"]}]},{"DOI":"10.13039\/501100023652","name":"Sveu\u010dili\u0161te u Rijeci","doi-asserted-by":"publisher","award":["uniri-mzi-25-52"],"award-info":[{"award-number":["uniri-mzi-25-52"]}],"id":[{"id":"10.13039\/501100023652","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Amelia Ltd","award":["in-kind support"],"award-info":[{"award-number":["in-kind support"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,7,23]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Antimicrobial resistance is a major global health threat. Intestinal carriage of multidrug-resistant organisms (MDRO) increases the risk of subsequent infection and contributes to onward transmission. Current decolonisation strategies are limited by insufficient evidence of efficacy and safety. Faecal microbiota transplantation (FMT) has emerged as a potential microbiota-based approach for intestinal MDRO decolonisation, but available evidence remains heterogeneous and data on lyophilised capsule formulations are scarce. This study aims to evaluate the efficacy and safety of oral lyophilised FMT capsules for intestinal decolonisation of MDROs in adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a single-centre, randomised, double-blind, placebo-controlled trial that will enrol 48 adults with confirmed intestinal carriage of MDROs. Participants will be randomised in a 1:1 ratio to receive either lyophilised FMT capsules or matching placebo capsules. The intervention consists of 18 gastro-resistant capsules administered over three consecutive days. Participants will be followed for 180 days, with study visits on days 7, 30, 90 and 180. The primary outcome is the proportion of participants without intestinal MDRO carriage at day 180, determined by stool sample or rectal swab culture. Secondary outcomes include early decolonisation at day 30, time to decolonisation, incidence of MDRO-related infections and safety outcomes including adverse events. Analyses will be performed primarily on an intention-to-treat basis, with prespecified sensitivity analyses for missing outcome data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study has been approved by the Ethics Committee of the Clinical Hospital Centre Rijeka, the Ethics Committee of the Teaching Institute of Public Health of Primorsko-Goranska County, and the Ethics Committee for Biomedical Research of the Faculty of Medicine, University of Rijeka. Written informed consent will be obtained from all participants before enrolment. Study findings will be disseminated through peer-reviewed publications and presentations at scientific meetings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT07106580\">NCT07106580<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-119249","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:05:45Z","timestamp":1787915145000},"page":"e119249","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Lyophilised faecal microbiota transplantation capsules for intestinal multidrug-resistant organism decolonisation: protocol for a randomised, double-blind, placebo-controlled trial"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct07106580","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct07106580","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1640-1421","authenticated-orcid":false,"given":"Igor","family":"Rubini\u0107","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Clinical Hospital Center Rijeka, Rijeka, Croatia"},{"name":"Department of Basic and Clinical Pharmacology and Toxicology, University of Rijeka, Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Pal\u010devski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Clinical Hospital Center Rijeka, Rijeka, Croatia"},{"name":"Department of Internal Medicine, University of Rijeka, Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tea","family":"Rosovi\u0107","sequence":"additional","affiliation":[{"name":"Polyclinic GrandMed, Opatija, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0161a","family":"Antoni\u0107","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Parasitology, University of Rijeka, Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a","family":"Sko\u010dibu\u0161i\u0107","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Clinical Hospital Center Rijeka, Rijeka, Croatia"},{"name":"Department of Health Ecology, University of Rijeka, Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivica","family":"Cepanec","sequence":"additional","affiliation":[{"name":"Amelia Ltd, Kri\u017e, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdravka","family":"Kne\u017eevi\u0107","sequence":"additional","affiliation":[{"name":"Jadran Galenic Laboratory, Rijeka, Primorje-Gorski Kotar County, Croatia"},{"name":"Hikma Pharmaceuticals PLC, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"\u0160anti\u0107","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Parasitology, University of Rijeka, Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4758-1717","authenticated-orcid":false,"given":"Goran","family":"Hauser","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Clinical Hospital Center Rijeka, Rijeka, Croatia"},{"name":"Department of Internal Medicine, University of Rijeka, Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Vlahovi\u0107-Pal\u010devski","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Clinical Hospital Center Rijeka, Rijeka, Croatia"},{"name":"Department of Basic and Clinical Pharmacology and Toxicology, University of Rijeka, Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"2026082804051230000_16.8.e119249.1","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/s41564-019-0503-9","article-title":"Defining and combating antibiotic resistance from One Health and Global Health perspectives","volume":"4","author":"Hernando-Amado","year":"2019","journal-title":"Nat Microbiol"},{"key":"2026082804051230000_16.8.e119249.2","unstructured":"World Health Organization . Antimicrobial resistance, Available: https:\/\/www.who.int\/. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance [Accessed 6 Mar 2026]."},{"key":"2026082804051230000_16.8.e119249.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0\/ATTACHMENT\/4504FC2B-08AE-46D6-BD75-80811DF8B5E6\/MMC1.PDF"},{"key":"2026082804051230000_16.8.e119249.4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/1475-6773.13135","article-title":"The incremental cost of infections associated with multidrug-resistant organisms in the inpatient hospital setting-A national estimate","volume":"54","author":"Johnston","year":"2019","journal-title":"Health Serv Res"},{"key":"2026082804051230000_16.8.e119249.5","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.7.17-00237"},{"key":"2026082804051230000_16.8.e119249.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2004.07.004"},{"key":"2026082804051230000_16.8.e119249.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-021-11451-y","article-title":"Multi-country cross-sectional study of colonization with multidrug-resistant organisms: protocol and methods for the Antibiotic Resistance in Communities and Hospitals (ARCH) studies","volume":"21","author":"Sharma","year":"2021","journal-title":"BMC Public Health"},{"key":"2026082804051230000_16.8.e119249.8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jhin.2016.05.018","article-title":"Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers","volume":"94","author":"Dickstein","year":"2016","journal-title":"J Hosp Infect"},{"key":"2026082804051230000_16.8.e119249.9","doi-asserted-by":"publisher","DOI":"10.1016\/J.CMI.2019.01.005"},{"key":"2026082804051230000_16.8.e119249.10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.cmi.2019.04.006","article-title":"Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review","volume":"25","author":"Saha","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2026082804051230000_16.8.e119249.11","doi-asserted-by":"publisher","DOI":"10.1097\/mog.0000000000000792"},{"key":"2026082804051230000_16.8.e119249.12","doi-asserted-by":"crossref","unstructured":"Cold F , Baunwall SMD , Dahlerup JF , et al . Systematic review with meta-analysis: encapsulated faecal microbiota transplantation - evidence for clinical efficacy. Ther Adv Gastroenterol 2021;14. doi:10.1177\/17562848211041004","DOI":"10.1177\/17562848211041004"},{"key":"2026082804051230000_16.8.e119249.13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10620-020-06185-7","article-title":"Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis","volume":"66","author":"Ramai","year":"2021","journal-title":"Dig Dis Sci"},{"key":"2026082804051230000_16.8.e119249.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17077"},{"key":"2026082804051230000_16.8.e119249.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.13875"},{"key":"2026082804051230000_16.8.e119249.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.08.012"},{"key":"2026082804051230000_16.8.e119249.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2019.12.022"},{"key":"2026082804051230000_16.8.e119249.18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.12688\/openreseurope.16825.1","article-title":"Lyophilized fecal microbiome transfer for primary Clostridioides difficile infection: a multicenter randomized controlled trial (DONATE Study)","volume":"4","author":"Pitashny","year":"2024","journal-title":"Open Res Europe"},{"key":"2026082804051230000_16.8.e119249.19","unstructured":"About us . Clin Hosp Cent Rij, Available: https:\/\/kbc-rijeka.hr\/about-us\/?lang=en"},{"key":"2026082804051230000_16.8.e119249.20","unstructured":"Clinical Trial Randomization Tool, Available: https:\/\/ctrandomization.cancer.gov\/"},{"key":"2026082804051230000_16.8.e119249.21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/14787210.2019.1645007","article-title":"Strategies for the eradication of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae intestinal carriage","volume":"17","author":"Catho","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2026082804051230000_16.8.e119249.22","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2356279","article-title":"The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes","volume":"16","author":"Rahman","year":"2024","journal-title":"Gut Microbes"},{"key":"2026082804051230000_16.8.e119249.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00933-y"},{"key":"2026082804051230000_16.8.e119249.24","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae467"},{"key":"2026082804051230000_16.8.e119249.25","doi-asserted-by":"crossref","first-page":"107561","DOI":"10.1016\/j.ijantimicag.2025.107561","article-title":"Lyophilised fecal microbiota transfer in capsules for recurrent Clostridioides difficile infection","volume":"66","author":"Daneri","year":"2025","journal-title":"Int J Antimicrob Agents"},{"key":"2026082804051230000_16.8.e119249.26","doi-asserted-by":"crossref","first-page":"106504","DOI":"10.1016\/j.jinf.2025.106504","article-title":"Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trial","volume":"91","author":"Merrick","year":"2025","journal-title":"J Infect"},{"key":"2026082804051230000_16.8.e119249.27","doi-asserted-by":"crossref","unstructured":"Miller JM , Binnicker MJ , Campbell S , et al . Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis 2024.:ciae104. doi:10.1093\/cid\/ciae104","DOI":"10.1093\/cid\/ciae104"},{"key":"2026082804051230000_16.8.e119249.28","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313017"},{"key":"2026082804051230000_16.8.e119249.29","doi-asserted-by":"crossref","first-page":"125703","DOI":"10.1016\/j.ijpharm.2025.125703","article-title":"Bacterial diversity, viability and stability in lyophilised faecal microbiota capsules support ongoing clinical use","volume":"678","author":"Zain","year":"2025","journal-title":"Int J Pharm"},{"key":"2026082804051230000_16.8.e119249.30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jinf.2020.09.003","article-title":"Fecal Microbiota Transplantation for multidrug-resistant organism: Efficacy and Response prediction","volume":"81","author":"Seong","year":"2020","journal-title":"J Infect"},{"key":"2026082804051230000_16.8.e119249.31","article-title":"Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile)","volume":"4","author":"Minkoff","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2026082804051230000_16.8.e119249.32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/07853890.2019.1662477","article-title":"Efficacy and safety of fecal microbiota transplantation for decolonization of intestinal multidrug-resistant microorganism carriage: beyond Clostridioides difficile infection","volume":"51","author":"Yoon","year":"2019","journal-title":"Ann Med"},{"key":"2026082804051230000_16.8.e119249.33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhin.2019.03.010","article-title":"Faecal microbiota transplantation for the decolonization of antibiotic-resistant bacteria in the gut: a systematic review and meta-analysis","volume":"102","author":"Tavoukjian","year":"2019","journal-title":"J Hosp Infect"},{"key":"2026082804051230000_16.8.e119249.34","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/cid\/ciaa948","article-title":"Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms","volume":"72","author":"Ghani","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026082804051230000_16.8.e119249.35","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa737"},{"key":"2026082804051230000_16.8.e119249.36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205064","article-title":"Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial","volume":"13","author":"Jiang","year":"2018","journal-title":"PLoS One"},{"key":"2026082804051230000_16.8.e119249.37","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16148"},{"key":"2026082804051230000_16.8.e119249.38","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-335077"},{"key":"2026082804051230000_16.8.e119249.39","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02638-15"},{"key":"2026082804051230000_16.8.e119249.40","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01092-13"},{"key":"2026082804051230000_16.8.e119249.41","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081477","article-title":"SPIRIT 2025 statement: updated guideline for protocols of randomised trials","volume":"389","author":"Chan","year":"2025","journal-title":"BMJ"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-119249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:05:49Z","timestamp":1787915149000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-119249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,28]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjopen-2026-119249"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-119249","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}